Healthcare: The 'contentious' global issue yielding attractive opportunities

Cutting costs - and political legacies - dominating the US

clock • 4 min read

Healthcare, and more importantly how it should be paid for, is one of the most contentious issues in the US.

The sector is a political battleground and has proven a key divisive issue between the Democratic and Republican parties, with voices on all sides demanding change.  'Political football' NHS: Investing in healthcarein 2019 Top-level rhetoric from President Donald Trump and the Democrats with their eyes on the 2020 election, and the policies that could emerge as a result, look set to bring real, sweeping changes to the sector.  Widespread changes Trump has his sights set on dismantling Barack Obama's Affordable Care Act, but also on cutting the cost of drugs - a move that is alrea...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot